Although BRAF (V600E) mutations are the most frequent alteration in PTC, thyroid cancers can also be driven by point mutations in RET, RAS, EIF1AX, TP53, kinase gene fusions, and arm-level chromosome changes [28]. This evidence concerns the gene TP53 and thyroid cancer.